The Current Ratio as of November 2025 (TTM) for AnPac Bio-Medical Science Co., Ltd. (ANPC) is 0.32

According to AnPac Bio-Medical Science Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.32. This represents a change of -41.77% compared to the average of 0.56 of the last 4 quarters.

AnPac Bio-Medical Science Co., Ltd. (ANPC) Historical Current Ratio (quarterly & annually)

How has ANPC Current Ratio performed in the past?

The mean historical Current Ratio of AnPac Bio-Medical Science Co., Ltd. over the last ten years is 0.39. The current 0.32 Current Ratio has changed 8.27% with respect to the historical average. Over the past ten years (40 quarters), ANPC's Current Ratio was at its highest in in the June 2020 quarter at 0.94. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

AnPac Bio-Medical Science Co., Ltd. (ANPC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AnPac Bio-Medical Science Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AnPac Bio-Medical Science Co., Ltd. (ANPC) Average Current Ratio

How has ANPC Current Ratio performed in the past?

The current Current Ratio of AnPac Bio-Medical Science Co., Ltd. (ANPC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AnPac Bio-Medical Science Co., Ltd. (ANPC) Current Ratio vs. Peers

How is ANPC’s Current Ratio compared to its peers?

AnPac Bio-Medical Science Co., Ltd.’s Current Ratio is less than Freeline Therapeutics Holdings plc (2.18), less than Serina Therapeutics, Inc. (2.24), less than LakeShore Biopharma Co., Ltd (1.02), less than Allakos Inc. (14.23), less than Liminal BioSciences Inc. (4.09), less than Marinus Pharmaceuticals, Inc. (1.66), less than Angion Biomedica Corp. (3.29), less than Elevation Oncology, Inc. (19.40), less than Vincerx Pharma, Inc. (1.79), less than Gemini Therapeutics, Inc. (0),

Build a custom stock screener for AnPac Bio-Medical Science Co., Ltd. (ANPC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AnPac Bio-Medical Science Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AnPac Bio-Medical Science Co., Ltd. (ANPC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AnPac Bio-Medical Science Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.